BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37706110)

  • 21. [Role of the hepatitis Delta virus on the pathogenesis of hepatic cirrhosis and hepatocellular carcinoma. Recent advances].
    Romeo R
    Recenti Prog Med; 2010 Feb; 101(2):52-6. PubMed ID: 20433000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule libraries.
    Tseligka ED; Conzelmann S; Cambet Y; Schaer T; Negro F; Clément S
    JHEP Rep; 2023 Mar; 5(3):100652. PubMed ID: 36704052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood.
    Chang MH; Chen PJ; Chen JY; Lai MY; Hsu HC; Lian DC; Liu YG; Chen DS
    Hepatology; 1991 Feb; 13(2):316-20. PubMed ID: 1847352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus pathogenesis relevant immunosignals uncovering amino acids utilization related risk factors guide artificial intelligence-based precision medicine.
    Huang J; Zhao C; Zhang X; Zhao Q; Zhang Y; Chen L; Dai G
    Front Pharmacol; 2022; 13():1079566. PubMed ID: 36569318
    [No Abstract]   [Full Text] [Related]  

  • 25. Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis.
    Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y
    Turk J Gastroenterol; 2022 Feb; 33(2):136-144. PubMed ID: 35115293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Identification of Bridge Genes to Explain the Progression from Chronic Hepatitis B Virus Infection to Hepatocellular Carcinoma.
    Nong W; Ma L; Lan B; Liu N; Yang H; Lao X; Deng Q; Huang Z
    J Inflamm Res; 2021; 14():1613-1624. PubMed ID: 33907440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosome-derived differentiation antagonizing non-protein coding RNA with risk of hepatitis C virus-related hepatocellular carcinoma recurrence.
    Wang SC; Li CY; Chang WT; Cheng WC; Yen CH; Tu WY; Lin ZY; Lin CC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Chen YL; Yu ML
    Liver Int; 2021 May; 41(5):956-968. PubMed ID: 33346937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.
    Kurokawa K; Ohki T; Kato J; Fukumura Y; Imai M; Shibata C; Arai J; Kondo M; Takagi K; Kojima K; Seki M; Mori M; Toda N; Tagawa K
    J Med Case Rep; 2020 May; 14(1):62. PubMed ID: 32456712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis.
    Gao X; Yang HI; Trinh H; Jeong D; Li J; Zhang J; Le A; Hoang J; Nguyen P; Henry L; Nguyen MH
    Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1207-1211. PubMed ID: 32129773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
    Xiang LY; Ou HH; Liu XC; Chen ZJ; Li XH; Huang Y; Yang DH
    Tumour Biol; 2017 Jun; 39(6):1010428317709128. PubMed ID: 28639884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner.
    Gai X; Zhao P; Pan Y; Shan H; Yue X; Du J; Zhang Z; Liu P; Ma H; Guo M; Yang X; Sun W; Gao L; Ma C; Liang X
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1174-85. PubMed ID: 23542016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of HBV genotypes of tumor tissues and serum by a fluorescence polarization assay in north-western China's hepatocellular carcinoma patients.
    Lu J; Gong W; Cheng H; Wu Z; Li D; Wang X; Liang P; Zhang J
    Virol J; 2011 Jul; 8():362. PubMed ID: 21781311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
    Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
    Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
    Tung CF; Yang DY; Hu WH; Peng YC; Chow WK; Chen GH
    Hepatogastroenterology; 2003; 50(53):1564-8. PubMed ID: 14571787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ RT-PCR detection of hepatitis C virus genotypes in Chinese patients with hepatocellular carcinoma.
    Su YH; Lu SL; Gu YH; Zhu TF; Zhu SN
    J Exp Clin Cancer Res; 2002 Dec; 21(4):591-8. PubMed ID: 12636107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis.
    Naoumov NV; Chokshi S; Metivier E; Maertens G; Johnson PJ; Williams R
    J Hepatol; 1997 Aug; 27(2):331-6. PubMed ID: 9288608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.
    Mazzella G; Accogli E; Sottili S; Festi D; Orsini M; Salzetta A; Novelli V; Cipolla A; Fabbri C; Pezzoli A; Roda E
    J Hepatol; 1996 Feb; 24(2):141-7. PubMed ID: 8907566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HCV-associated hepatocellular carcinoma without cirrhosis.
    el-Refaie A; Savage K; Bhattacharya S; Khakoo S; Harrison TJ; el-Batanony M; Soliman el-S ; Nasr S; Mokhtar N; Amer K; Scheuer PJ; Dhillon AP
    J Hepatol; 1996 Mar; 24(3):277-85. PubMed ID: 8778193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A lack of direct role of hepatitis B virus in the activation of ras and c-myc oncogenes in human hepatocellular carcinogenesis.
    Lee HS; Rajagopalan MS; Vyas GN
    Hepatology; 1988; 8(5):1116-20. PubMed ID: 2843452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections.
    Korba BE; Wells FV; Baldwin B; Cote PJ; Tennant BC; Popper H; Gerin JL
    Hepatology; 1989 Mar; 9(3):461-70. PubMed ID: 2465987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.